Canada markets closed
  • S&P/TSX

    19,991.88
    +105.94 (+0.53%)
     
  • S&P 500

    4,207.27
    -2.97 (-0.07%)
     
  • DOW

    33,336.67
    +27.16 (+0.08%)
     
  • CAD/USD

    0.7834
    +0.0005 (+0.06%)
     
  • CRUDE OIL

    94.05
    +2.12 (+2.31%)
     
  • BTC-CAD

    30,899.44
    +291.81 (+0.95%)
     
  • CMC Crypto 200

    573.13
    -1.61 (-0.28%)
     
  • GOLD FUTURES

    1,805.00
    -8.70 (-0.48%)
     
  • RUSSELL 2000

    1,975.26
    +6.01 (+0.31%)
     
  • 10-Yr Bond

    2.8880
    +0.1020 (+3.66%)
     
  • NASDAQ futures

    13,344.25
    -47.75 (-0.36%)
     
  • VOLATILITY

    20.20
    +0.46 (+2.33%)
     
  • FTSE

    7,465.91
    -41.20 (-0.55%)
     
  • NIKKEI 225

    27,819.33
    -180.63 (-0.65%)
     
  • CAD/EUR

    0.7587
    -0.0010 (-0.13%)
     

U.S. administers 464.4 mln doses of COVID-19 vaccines - CDC

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Dec 2 (Reuters) - The United States has administered 464,445,580 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 578,263,565 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 462,263,845 vaccine doses the CDC said had gone into arms by Dec. 1 out of 575,721,925 doses delivered.

The agency said 234,269,053 people had received at least one dose while 197,838,728 people are fully vaccinated as of 6:00 a.m. ET on Thursday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine.

About 43.0 million people received a booster dose of COVID-19 vaccine from either Pfizer or Moderna or J&J. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting